Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.

MLA

Pop, Diana Ioana, et al. “Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.” Clinical Pharmacology in Drug Development, vol. 8, no. 1, Jan. 2019, pp. 16–21. EBSCOhost, https://doi.org/10.1002/cpdd.445.

APA

Pop, D. I., Oroian, M., Bhardwaj, S., Marcovici, A., Khuroo, A., Kochhar, R., & Vlase, L. (2019). Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions. Clinical Pharmacology in Drug Development, 8(1), 16–21. https://doi.org/10.1002/cpdd.445

Chicago

Pop, Diana Ioana, Monica Oroian, Sandeep Bhardwaj, Adriana Marcovici, Arshad Khuroo, Ravi Kochhar, and Laurian Vlase. 2019. “Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.” Clinical Pharmacology in Drug Development 8 (1): 16–21. doi:10.1002/cpdd.445.